Schizophrenia Trial, Recruiting NCT07441928 Sponsor: The Hong Kong Polytechnic University Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07441928
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with schizophrenia or schizoaffective disorder and have been followed up by a doctor or service for at least one year
  • People who have been taking antipsychotic medication regularly for at least three months with good adherence to their prescribed doses
  • People aged 18 years or older
  • People who are able to speak and communicate in Cantonese

Who may not be able to join:

  • People who have, or have had in the past, any other type of psychotic disorder
  • People who have had thoughts of suicide or self-harm, even briefly, or have harmed themselves in the past
  • People with a known history of violent or aggressive behaviour, or who have had any involvement with the legal system related to such behaviour
  • People whose care has been classified as special or intensive care due to serious incidents such as arson, assault, rape, or murder
  • People who have ever had a problem with substance abuse (such as opioids, cocaine, marijuana, or stimulants), or who are currently receiving treatment for substance abuse
  • People whose alcohol intake over the last six months has regularly exceeded 25 standard drinks per week (for men) or 20 standard drinks per week (for women)
  • People who received a diagnosis of alcohol or drug dependence within the year before joining the trial
  • People who are pregnant, breastfeeding, or planning to become pregnant during the study period
  • People who have a current or past diagnosis of attention-deficit hyperactivity disorder (ADHD)
  • People who have a history of epilepsy or a seizure disorder
  • People who experience disorientation, have a developmental disability, or have an organic mental disorder (a mental condition caused by a physical condition affecting the brain)
  • People who do not meet the brain scanning (fMRI) safety requirements set by the University Research Facility in Behavioural and Systems Neuroscience (UBSN) at PolyU (confirm with trial site for full details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yim Wah Mak, School of Nursing, The Hong Kong Polytechnic University

Phone: 852-2766 6421

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Hong Kong Polytechnic University
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
30 April 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Biochemically validated self-reported 7-day point prevalence tobacco abstinence; Chinese version of the Brief Psychiatric Rating Scale; functional neuroimaging (fMRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov